Buspirone Therapy for Maladaptive Behavior and Anxiety in Developmentally Disabled Persons

Overview

Journal J Clin Psychiatry

Specialty Psychiatry

Date 1989 Oct 1

PMID 2793836

Citations 12

Authors

J J Ratey

R Sovner

E Mikkelsen

H E Chmielinski

Affiliations

Soon will be listed here.

Abstract

The authors used buspirone, a new anxiolytic agent that has a low side effect profile, to treat 14 developmentally disabled individuals who demonstrated anxiety as well as aggressive and self-injurious behaviors. Nine of the 14 individuals responded favorably to the drug. The authors present case reports for 3 of the responders and discuss the clinical implications of buspirone therapy.

Citing Articles

Effect of HPMC and mannitol on drug release and bioadhesion behavior of buccal discs of buspirone hydrochloride: In-vitro and in-vivo pharmacokinetic studies.

Jaipal A, Pandey M, Charde S, Raut P, Prasanth K, Prasad R Saudi Pharm J. 2015; 23(3):315-26.

PMID: 26106280 PMC: 4475836. DOI: 10.1016/j.jsps.2014.11.012.

Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.

Minshawi N, Hurwitz S, Morriss D, McDougle C J Autism Dev Disord. 2014; 45(6):1541-68.

PMID: 25395094 DOI: 10.1007/s10803-014-2307-3.

Self-injurious behaviour in autistic children: a neuro-developmental theory of social and environmental isolation.

Devine D Psychopharmacology (Berl). 2013; 231(6):979-97.

PMID: 24057764 DOI: 10.1007/s00213-013-3279-2.

Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression.

Takahashi A, Quadros I, de Almeida R, Miczek K Psychopharmacology (Berl). 2010; 213(2-3):183-212.

PMID: 20938650 PMC: 3684010. DOI: 10.1007/s00213-010-2000-y.

Anxiety disorders in persons with developmental disabilities: empirically informed diagnosis and treatment. Reviews literature on anxiety disorders in DD population with practical take-home messages for the clinician.

Davis E, Saeed S, Antonacci D Psychiatr Q. 2008; 79(3):249-63.

PMID: 18726156 DOI: 10.1007/s11126-008-9081-3.